首页> 外文OA文献 >Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial

【2h】

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial

机译：推进基底胰岛素沼灵治疗的折叠选项：测试Lixisenatide Plus基础胰岛素与胰岛素青氯酸盐，也可以是2型糖尿病的基础或基础推子：GetGoal Duo-2试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Julio Rosenstock; Bruno Guerci; Markolf Hanefeld; Sandro Gentile; Ronnie Aronson; Francisco J. Tinahones; Christine Roy-Duval; Elisabeth Souhami; Marek Wardecki; Jenny Ye; Riccardo Perfetti; Simon Heller;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial [J] . Rosenstock Julio, Guerci Bruno, Hanefeld Markolf, Diabetes care . 2016,第8期

机译：进行基础胰岛素甘草碱治疗的多种方案：在2型糖尿病中，测试利西拉来特加基础胰岛素与胰岛素谷胱甘肽的关系包括基础+或基础-青霉石：GetGoal Duo-2试验
2. Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections. [J] . M C Riddle, J Rosenstock, A Vlajnic, Diabetes, obesity & metabolism . 2014,第5期

机译：两种开始和发展2型糖尿病的胰岛素的方式的随机1年比较：每日两次预混胰岛素与基础胰岛素加基础加一种餐前胰岛素或基础推注（最多3次进样）。
3. Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial [J] . Jia Weiping, Xiao Xinhua, Ji Qiuhe, The lancet. Diabetes & endocrinology. . 2015,第4期

机译：东亚2型糖尿病患者每日两次三次预混胰岛素（赖脯胰岛素预混物）与基底推注（甘精胰岛素每天一次加三餐膳食赖脯胰岛素）的比较，每日两次预混胰岛素不能充分控制：标签，随机，对照试验
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Physiology and pharmacology of diabetes therapies in the cat: Insulin detemir, insulin glargine, exenatide and the incretin effect. [D] . Gilor, Chen. 2010

机译：猫的糖尿病疗法的生理和药理作用：地特胰岛素，甘精胰岛素，艾塞那肽和肠降血糖素作用。
6. Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals [O] . Elizabeth Mary Lamos, Lisa M. Younk, Donna B. Tate, 2016

机译：甘精胰岛素–甘草胰岛素基础快速推注和每日两次预混合类似胰岛素在1顿3型标准餐中的药代动力学和药效学
7. Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral Agents: Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy [O] . J. Rosenstock, A. J. Ahmann, G. Colon, 2007

机译：促进胰岛素治疗的2型糖尿病患者，以前用狼氨酸加口服药剂处理：折叠预混合（胰岛素Lispro protamine悬浮液/ LISPRO）与基底/推注（龟头/ LISPRO）治疗

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial

著录项

引文网络

相似文献

相关主题

期刊订阅